Ratings Vetoquinol SA

Equities

VETO

FR0004186856

Market Closed - Euronext Paris Other stock markets 11:35:21 2024-04-26 am EDT			5-day change	1st Jan Change
99.6 ^EUR	+1.63%		+3.64%	-2.73%

Mar. 20	Vetoquinol SA Proposes Dividend	CI
Mar. 20	Vetoquinol SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Strengths

Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Pharmaceuticals

	1st Jan change	Capi.	ESG Refinitiv
VETOQUINOL SA	-2.73%	1.26B	-
ZOETIS INC.	-19.73%	72.39B	B+
ELANCO ANIMAL HEALTH INCORPORATED	-11.01%	6.54B	B-
BLUESTAR ADISSEO COMPANY	+15.88%	3.43B	B-
VIRBAC	-2.92%	3.12B	B-
VIMIAN GROUP AB	-0.68%	1.4B	-
JINYU BIO-TECHNOLOGY CO., LTD.	-17.27%	1.34B	B
WUHAN KEQIAN BIOLOGY CO.,LTD	-14.67%	1.12B	-
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-5.37%	990M	-
PULIKE BIOLOGICAL ENGINEERING, INC.	-24.06%	805M	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes